Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Dorsavi.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Genetic Technologies jumps after EasyDNA acquisition ups cash receipts by $850k
News
Closing Bell: ASX rises again, hits all time high
Health & Biotech
ASX health stocks: dorsaVi leads the pack with 12% jump on major contract extension
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
Weekly ASX small cap wrap: Who are the cup winners and wooden spoon recipients?
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Check up: dorsaVi leads ASX health gainers with 60pc rise
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Check up: Speeding tickets all round
Tech
Trading with Focus: Looking for the next 1500pc ASX trade?
Experts
Scopo’s health powerplays: Markets are getting back to normal
News
Weekly ASX small cap wrap: Who’s trying to turn seat warming into an ‘as-a-service’ feature?
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s ramping things up today?
News
Tech: dorsaVi becomes latest small cap to post 10x surge on new deal with QBE
News
10 at 10: These ASX stocks are blowing their trumpets this morning
Health & Biotech
